Prevention of migraine.
Dodick
David W
DW
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001521:Behavior Therapy / Q000379:methods*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists